The Importance of Ongoing 
Research in Alzheimer’s Disease 
Watch the video here
TauRx exists to solve one of the world’s biggest challenges – beating Alzheimer’s and other degenerative brain diseases via a completely new approach 
Read more
We combine pioneering research and drug development 
Read more
Our protein aggregation inhibitors aim to halt disease progression by targeting the underlying pathology of dementia 
Read more
Protein aggregation inhibitor LMTX
®
 is a patented novel chemical entity currently in development for the prevention of Alzheimer’s and 
bv
FTD 
Read more
Phase 3 trials for LMTX
®
 now completed - over 1,900 patients, across 20 countries 
Read more
toggle menu
Home
About us
Science
Product Pipeline
Clinical Trials
Business Development
Jobs
Press Room
Pioneering Science
The tau tangle pathway is a key driver of Alzheimer’s disease leading to loss of neuronal function, spread of pathology and clinical symptoms. 
View
Alzheimer's Innovations
TauRx’s tau aggregation inhibitors are the outcome of nearly 30 years of research, preclinical and clinical investigations. 
View
Clinical
Trials
LUCIDITY, a new clinical trial examining the effects of LMTX
®
 in patients with mild Alzheimer’s disease, is now underway. 
View
TauRx and LMTX
Claude Wischik, TauRx CEO, discusses the clinical development of LMTX, and what the recent Phase 3 results mean for TauRx’s on-going development programme.
TauRx’s Research
Claude Wischik explores TauRx’s broad-based research activities including its pioneering work on both the treatment and early diagnosis of AD.
Alzheimer’s Disease and Tau Pathology
Claude Wischik talks about how the Alzheimer’s research landscape has evolved over the past thirty years and the impact of the disease on patients and their families.
August 2018
Bringing Alzheimer’s in from…
Read More
July 2018
LUCIDITY Study – Protocol…
Read More
January 2018
Alzheimer candidate LMTX®…
Read More
November 2017
Second Phase 3 Study Results…
Read More
November 2017
Upcoming Clinical Trial
Read More
view all
Home
About us
Science
Product Pipeline
Clinical Trials
Business Development
Jobs
Press Room
© Copyright TauRx 2016